Stock STAA STAAR SURGICAL COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials STAAR Surgical Company

Equities

STAA

US8523123052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
41.53 USD +2.29% Intraday chart for STAAR Surgical Company +0.90% +33.07%
May. 08 Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating MT
May. 08 Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,628 3,560 4,414 2,309 1,523 2,040 - -
Enterprise Value (EV) 1 1,628 3,560 4,414 2,309 1,302 1,808 1,800 1,776
P/E ratio 122 x 644 x 185 x 60.6 x 72.6 x -45,637 x 99.8 x 57 x
Yield - - - - - - - -
Capitalization / Revenue 10.8 x 21.8 x 19.2 x 8.12 x 4.72 x 6 x 5.16 x 4.36 x
EV / Revenue 10.8 x 21.8 x 19.2 x 8.12 x 4.04 x 5.32 x 4.55 x 3.79 x
EV / EBITDA 105 x - 85.6 x 33.6 x 23 x 46.2 x 29.8 x 19.2 x
EV / FCF 104 x 284 x 146 x 131 x -362 x 225 x 83.5 x 48 x
FCF Yield 0.96% 0.35% 0.69% 0.76% -0.28% 0.44% 1.2% 2.08%
Price to Book - - - - 4 x 5.13 x 4.77 x 4.18 x
Nbr of stocks (in thousands) 44,598 46,099 47,597 48,202 48,805 49,121 - -
Reference price 2 36.50 77.22 92.74 47.91 31.21 41.53 41.53 41.53
Announcement Date 2/26/20 2/24/21 2/23/22 2/21/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 150.2 163.5 230.5 284.4 322.4 339.9 395.4 468.4
EBITDA 1 15.55 - 51.59 68.68 56.74 39.1 60.46 92.47
EBIT 1 11.85 6.769 33.34 43.8 28.1 3.927 31.49 55.71
Operating Margin 7.89% 4.14% 14.47% 15.4% 8.71% 1.16% 7.96% 11.89%
Earnings before Tax (EBT) 1 13.03 8.267 31.3 45.8 33.7 4.848 34.38 58.35
Net income 1 14.05 5.913 24.5 39 21.35 -0.6195 18.42 39.31
Net margin 9.35% 3.62% 10.63% 13.72% 6.62% -0.18% 4.66% 8.39%
EPS 2 0.3000 0.1200 0.5000 0.7900 0.4300 -0.000910 0.4160 0.7288
Free Cash Flow 1 15.7 12.55 30.32 17.61 -3.594 8.018 21.54 37
FCF margin 10.45% 7.68% 13.15% 6.19% -1.11% 2.36% 5.45% 7.9%
FCF Conversion (EBITDA) 100.96% - 58.77% 25.64% - 20.51% 35.63% 40.01%
FCF Conversion (Net income) 111.76% 212.19% 123.74% 45.14% - - 116.98% 94.13%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/26/20 2/24/21 2/23/22 2/21/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 59 63.2 81.1 76.05 64.04 73.53 92.31 80.31 76.27 77.36 95.19 87.34 80.14 86.85 110.5
EBITDA 1 11.95 13.12 23.81 20.52 7.345 9.985 18.47 16.48 11.95 5.295 16.6 11.22 5.991 7.171 24.37
EBIT 1 7.383 12.11 17.02 13.7 0.964 2.8 8.597 6.295 10.4 -2.281 7.504 1.945 -3.153 0.938 17.89
Operating Margin 12.51% 19.17% 20.99% 18.02% 1.51% 3.81% 9.31% 7.84% 13.64% -2.95% 7.88% 2.23% -3.93% 1.08% 16.19%
Earnings before Tax (EBT) 1 6.974 11.53 15.47 12.58 6.229 4.719 8.492 6.746 13.74 -2.211 7.724 2.225 -2.843 2.008 17.62
Net income 1 4.922 9.602 13.04 10.26 6.103 2.71 6.064 4.817 7.756 -3.339 4.66 1.038 -3.304 1.002 13.15
Net margin 8.34% 15.19% 16.08% 13.49% 9.53% 3.69% 6.57% 6% 10.17% -4.32% 4.9% 1.19% -4.12% 1.15% 11.89%
EPS 2 0.1000 0.1900 0.2600 0.2100 0.1200 0.0500 0.1200 0.1000 0.1600 -0.0700 0.0960 0.0230 -0.0570 0.0200 0.2520
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/23/22 5/4/22 8/10/22 11/2/22 2/21/23 5/3/23 8/2/23 11/1/23 2/26/24 5/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - - - 221 232 240 264
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 15.7 12.5 30.3 17.6 -3.59 8.02 21.5 37
ROE (net income / shareholders' equity) 8.79% 3.31% 10.8% 13.2% 5.91% 2.75% 8.06% 10.6%
ROA (Net income/ Total Assets) 6.79% 2.54% 8.12% 10.3% 4.7% 0.9% 6.25% -
Assets 1 206.9 232.5 301.6 380.5 453.8 -68.83 294.6 -
Book Value Per Share 2 - - - - 7.810 8.100 8.710 9.930
Cash Flow per Share 2 - - - - - 0.7100 0.6600 -
Capex 1 10.1 8.4 13.6 18.1 18.2 25.9 27.5 23
Capex / Sales 6.72% 5.14% 5.92% 6.37% 5.64% 7.61% 6.95% 4.91%
Announcement Date 2/26/20 2/24/21 2/23/22 2/21/23 2/26/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for STAAR Surgical Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
41.53 USD
Average target price
52.31 USD
Spread / Average Target
+25.96%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
STAAR SURGICAL COMPANY Stock STAAR Surgical Company
+33.07% 2.04B
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.24B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.76% 29.99B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-5.38% 23.69B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. STAA Stock
  4. Financials STAAR Surgical Company